Search research articles
Contact Us
Filters
Showing results (31-40 of 49) with videos related to
Page
of 5
Sort By:
AIDS Research and Human Retroviruses
|
December 16, 2000
Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir
M Levacher, F Bouscarat, R Landman, et al.
HIV Clinical Trials
|
September 3, 2009
Simplification and first validation of a short battery of patient questionnaires for clinical management of HIV-infected patients: The HIV-SQUAD (Symptom Quality of life Adherence) Questionnaire
B Spire, B Arnould, F Barbier, et al.
The New England Journal of Medicine
|
May 27, 1993
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group
P M Girard, R Landman, C Gaudebout, et al.
Lancet (London, England)
|
June 17, 1989
Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients
P M Girard, R Landman, C Gaudebout, et al.
The Journal of Antimicrobial Chemotherapy
|
June 10, 2021
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection
A Bachelard, V Isernia, D Vallois, et al.
The Journal of Antimicrobial Chemotherapy
|
February 29, 2012
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens
A G Marcelin, C Charpentier, M Wirden, et al.
Clinical Pharmacology in Drug Development
|
April 30, 2016
Pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in renal and hepatic impairment patients
Xuejun Chen, Jack G Shi, Thomas Emm, et al.
Journal of Clinical Pharmacology
|
January 25, 2011
The pharmacokinetics, pharmacodynamics, and safety of orally dosed INCB018424 phosphate in healthy volunteers
Jack G Shi, Xuejun Chen, Ryan F McGee, et al.
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-Deoxycytidine
Jonathan M O Rawson, Michele B Daly, Jiashu Xie, et al.
Journal of Molecular Biology
|
May 16, 2017
Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra
Jonathan M O Rawson, Daryl M Gohl, Sean R Landman, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 49) with videos related to
Sort By:
Page
of 5
AIDS Research and Human Retroviruses
|
December 16, 2000
Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir
M Levacher, F Bouscarat, R Landman, et al.
HIV Clinical Trials
|
September 3, 2009
Simplification and first validation of a short battery of patient questionnaires for clinical management of HIV-infected patients: The HIV-SQUAD (Symptom Quality of life Adherence) Questionnaire
B Spire, B Arnould, F Barbier, et al.
The New England Journal of Medicine
|
May 27, 1993
Dapsone-pyrimethamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. The PRIO Study Group
P M Girard, R Landman, C Gaudebout, et al.
Lancet (London, England)
|
June 17, 1989
Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in zidovudine-treated AIDS patients
P M Girard, R Landman, C Gaudebout, et al.
The Journal of Antimicrobial Chemotherapy
|
June 10, 2021
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/emtricitabine/tenofovir alafenamide initiated at the time of primary HIV infection
A Bachelard, V Isernia, D Vallois, et al.
The Journal of Antimicrobial Chemotherapy
|
February 29, 2012
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens
A G Marcelin, C Charpentier, M Wirden, et al.
Clinical Pharmacology in Drug Development
|
April 30, 2016
Pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in renal and hepatic impairment patients
Xuejun Chen, Jack G Shi, Thomas Emm, et al.
Journal of Clinical Pharmacology
|
January 25, 2011
The pharmacokinetics, pharmacodynamics, and safety of orally dosed INCB018424 phosphate in healthy volunteers
Jack G Shi, Xuejun Chen, Ryan F McGee, et al.
Antimicrobial Agents and Chemotherapy
|
February 3, 2016
5-Azacytidine Enhances the Mutagenesis of HIV-1 by Reduction to 5-Aza-2'-Deoxycytidine
Jonathan M O Rawson, Michele B Daly, Jiashu Xie, et al.
Journal of Molecular Biology
|
May 16, 2017
Single-Strand Consensus Sequencing Reveals that HIV Type but not Subtype Significantly Impacts Viral Mutation Frequencies and Spectra
Jonathan M O Rawson, Daryl M Gohl, Sean R Landman, et al.
Page
of 5